Thryvv : ratio page

Concord Biotech

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
51.68
0.00
0.00
0.00
0.00
PCE(x)
44.02
0.00
0.00
0.00
0.00
Price/Book(x)
10.43
0.00
0.00
0.00
0.00
EV/Net Sales(x)
15.62
0.00
-0.03
0.06
0.11
EV/Core EBITDA(x)
34.08
0.00
-0.06
0.10
0.23
EV/EBIT(x)
38.20
-0.01
-0.08
0.11
0.26
EV/CE(x)
10.36
0.00
-0.01
0.03
0.05
MCap / Sales
15.66
0.00
0.00
0.00
0.00
Growth Ratio:
Net Sales Growth(%)
19.20
19.67
15.56
20.42
0.00
Core EBITDA Growth(%)
21.38
29.11
-12.99
44.86
0.00
EBIT Growth(%)
25.30
36.18
-22.35
46.17
0.00
PAT Growth(%)
28.33
37.25
-25.53
39.02
0.00
EPS Growth(%)
28.33
-87.52
-25.51
38.99
0.00
Financial Stability Ratios:
Total Debt/Equity(x)
0.00
0.02
0.05
0.09
0.06
Current Ratio(x)
6.30
3.79
1.84
2.57
2.41
Quick Ratio(x)
4.84
2.69
1.27
1.92
1.91
Interest Cover(x)
130.57
33.85
39.72
299.68
183.92
Operational & Financial Ratios:
Earnings Per Share (Rs)
29.45
22.95
183.92
246.92
177.66
CEPS(Rs)
34.57
28.11
21.50
25.08
18.18
DPS(Rs)
8.75
6.83
51.20
74.15
6.00
Book NAV/Share(Rs)
145.93
123.31
1159.94
1050.75
809.87
Tax Rate(%)
25.32
25.44
26.35
24.89
20.86
Margin Ratios:
Core EBITDA Margin(%)
42.50
40.86
37.73
52.14
39.14
EBIT Margin(%)
40.88
38.89
33.56
49.89
41.07
Pre Tax Margin(%)
40.57
37.74
32.72
49.72
40.85
PAT Margin (%)
30.30
28.14
24.10
37.35
32.33
Cash Profit Margin (%)
35.57
34.47
30.99
41.73
36.40
Performance Ratios:
ROA(%)
19.17
15.92
12.43
19.89
16.11
ROE(%)
21.88
20.06
16.64
26.55
21.94
ROCE(%)
29.13
26.70
21.66
32.96
26.23
Asset Turnover(x)
0.63
0.57
0.52
0.53
0.50
Sales/Fixed Asset(x)
1.25
1.13
1.06
1.31
1.68
Working Capital/Sales(x)
1.35
1.59
2.52
1.69
1.66
Efficiency Ratios:
Fixed Capital/Sales(x)
0.80
0.89
0.94
0.76
0.60
Receivable days
111.87
108.22
102.99
104.76
128.17
Inventory Days
75.42
87.15
87.67
76.85
77.69
Payable days
149.88
179.16
144.10
192.42
200.10